drugset
drugset / Trial / NCT02810756

Study With Improved Solubility Pazopanib

NCT02810756 ↗

Phase 0 Completed 12 enrolled The Netherlands Cancer Institute
NaSingle-groupOpen-labelTreatment

Summary

The pharmacokinetics of a new formulation with Pazopanib will be studied. This will be done in a patient cohort of n = 12.

Timeline

Start
2016-09-15
Primary completion
2017-08-28
Completion
2017-08-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Pazopanib Small molecule — —

Indications

No indication recorded.